List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 3340 studies with search of:   United Kingdom
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
21 Active, not recruiting Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine
Conditions: Migraine;   Migraine Headache;   Migraine Disorders;   Migraine With Aura;   Migraine Without Aura
Interventions: Drug: AST-726 Low dose;   Drug: AST-726 High dose;   Drug: AST-726 Placebo
22 Completed Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The AURA Study (BY217/M2-124)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Roflumilast;   Drug: Placebo
23 Recruiting PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
Condition: Non Hodgkin Lymphoma
Interventions: Drug: enzastaurin;   Drug: placebo
24 Recruiting Study of Apixaban for the Prevention of Thrombosis-Related Events in Patients With Acute Medical Illness
Conditions: Venous Thrombosis;   Pulmonary Embolism
Interventions: Drug: Apixaban;   Drug: Enoxaparin
25 Recruiting Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney
Condition: Kidney Cancer
Interventions: Drug: carboplatin;   Drug: cyclophosphamide;   Drug: dactinomycin;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: melphalan;   Drug: vincristine sulfate;   Procedure: autologous bone marrow transplantation;   Procedure: conventional surgery;   Procedure: peripheral blood stem cell transplantation;   Procedure: radiation therapy
26 Active, not recruiting Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: gemtuzumab ozogamicin
27 Active, not recruiting Benign Prostatic Hyperplasia Trial With AVODART And Tamsulosin Combination Treatment
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: AVODART;   Drug: Tamsulosin
28 Completed Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed Epilepsy
Condition: Epilepsy
Intervention: Drug: LEVETIRACETAM (UCB)
29 Completed CUTE (Chronic Urticaria Treatment Evaluation)
Condition: Chronic Idiopathic Urticaria
Intervention: Drug: Levocetirizine
30 Recruiting Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Previously Untreated Stomach Cancer or Gastroesophageal Junction Cancer That Can Be Removed by Surgery
Condition: Gastric Cancer
Interventions: Drug: bevacizumab;   Drug: capecitabine;   Drug: cisplatin;   Drug: epirubicin hydrochloride;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
31 Recruiting Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer
Condition: Inflammatory Breast Cancer
Interventions: Drug: pazopanib (GW786034);   Drug: lapatinib (Tykerb)
32 Recruiting Long-Term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-Severe Dementia Associated With Parkinson's Disease (PDD)
Condition: Dementia Associated With Parkinson's Disease
Interventions: Drug: Rivastigmine capsule;   Drug: Rivastigmine transdermal patch
33 Completed Clinical Evaluation on Advanced Resynchronization
Conditions: Heart Failure;   Cardiomyopathy
Interventions: Device: New Living CHF;   Device: New Living CHF
34 Recruiting BI 44370 TA in Acute Migraine Attack
Condition: Migraine Disorders
Interventions: Drug: BI 44370 TA;   Drug: Eletriptan
35 Not yet recruiting The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Conditions: Atherosclerosis;   Cardiovascular Disease;   Coronary Heart Disease;   CV Risk
Interventions: Drug: Darapladib;   Drug: Placebo
36 Active, not recruiting Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer
Conditions: Colorectal Cancer;   Metastatic Cancer
Interventions: Drug: FOLFOX regimen;   Drug: bevacizumab;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin;   Procedure: conventional surgery;   Procedure: radiofrequency ablation
37 Completed Corticosteroid Therapy of Septic Shock - Corticus
Condition: Shock, Septic
Interventions: Drug: hydrocortisone sodium succinate;   Drug: Placebo
38 Terminated Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Cisplatin;   Drug: Gemcitabine;   Drug: PF-3512676;   Drug: Cisplatin;   Drug: Gemcitabine + Cisplatin
39 Recruiting Study to Test the Efficacy and Safety of the Beta-3 Agonist YM178 in Subjects With Symptoms of Overactive Bladder
Condition: Urinary Bladder, Overactive
Interventions: Drug: YM178;   Drug: Tolterodine 4 mg;   Drug: Placebo
40 Recruiting A Study for Patients With Erectile Dysfunction to Test Whether Tadalafil Taken Once a Day Can Better Improve Psychological Outcomes.
Condition: Erectile Dysfunction
Interventions: Drug: tadalafil;   Drug: sildenafil citrate;   Drug: tadalafil

Previous Page (1-20) Studies Shown (21-40) Next (41-60)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services